Final Agenda Released: February 9 'Pharma & MedTech Innovation Forum – Chengdu Station' Combines Technical Seminars and Resource Networking

Time:February 9, 2023 8:30-17:00

Location:2nd Floor, Building 3, Phase III, San Yi Innovation Center, Chengdu Medical City

On February 9, jointly hosted by Huoshi Shulian, Baicheng Pharmaceutical, and the Administrative Committee of Chengdu Medical City“Pharmaceutical and Medical Device Innovation Forum” Campus Tour & CBIB Index Key Industrial Park Showcase [Chengdu Stop]Confirmed: The event is restarting! As the first major conference of the year, it has invited over 10 industry-leading CXO representatives and clinical registration review experts to gather together.Chengdu Medical City, organize salons for discussions on innovative technologies in pharmaceuticals and medical devices, as well as resource matchmaking events.

Chengdu Medical City is one of the top 20 key biomedical industrial parks selected by the "China Biopharmaceutical Industry Development Index CBIB 2.0." It is also the most important area for Chengdu's development of the biopharmaceutical industry and has received honors such as "China's Most Potential Biopharmaceutical Park," "China's Most Distinctive Biopharmaceutical Park," and "Top 10 Best Medical Health Industrial Parks in China." Chengdu Medical City now gathers over 500 enterprises from the "three medical" industries, including biopharmaceuticals, medical devices, specialized hospitals, elderly care institutions, CROs, CSOs, CMOs, and upstream and downstream collaborative companies.February 9"Pharmaceutical and Medical Device Innovation Forum" Campus Tour & CBIB Index Key Industrial Park Showcase【Chengdu Station】, will bring comprehensive industrial resources to Chengdu Medical City, engaging with enterprises to jointly explore development trends and cutting-edge technologies in the pharmaceutical and medical device sectors.

Guiding Organizations:Chinese Society for Biotechnology

Co-organizers:Huoshi Shulian, Baicheng Medicine, Chengdu Medical City Administrative Committee

Conference Scale:100+ (split into morning and afternoon sessions)

Attendee Profile:Pharmaceutical and Medical Device R&D and Manufacturing Enterprises in the Industrial Park and Surrounding Urban Areas

This event adopts a “Conference + Exhibition” format, featuring a full-day agenda divided into a morning session focused on pharmaceutical innovation and an afternoon session dedicated to medical device innovation. Each session includes a special 20-minute resource promotion segment, recommending high-quality R&D and manufacturing service providers in the pharmaceutical and medical device industries to attendees, and distributing the “China Biopharmaceutical Industry Resource Handbook” by Huoshi Data Chain, providing one-time access to resources from over 100 pharmaceutical and medical device R&D suppliers. In addition, an exhibition area is set up concurrently with the conference, recruiting more than 10 innovative service providers to facilitate face-to-face communication between attending enterprises and service providers.

Morning: Pharmaceutical Session and Resource Matchmaking Meeting

8:30-8:40

Sign In

8:40-8:50

Opening Remarks by the Organizer

8:50-9:00  

Campus Introduction

Yang Jie | Deputy Secretary of the Party Working Committee, Chengdu Medical City

9:00-9:30  

Sharing on Application for Marketing Authorization Holder’s Manufacturing License and Quality System Establishment

Wang Zhen | Registration Director, Baicheng Medicine

9:30-10:00

Human Pharmacokinetic Prediction: Principles and Strategies

Guo Jianjun | Chairman and General Manager, Hengxing Pharmaceutical

10:00-10:30

Innovative Drug R&D Strategies and Risk Control under the Internationalization of Regulatory Standards

Li Jigang | Chief Medical Officer, NoSiger

10:30-10:45

Pharmaceutical Special Session: Resource Promotion

10:45-10:55

Tea Break

10:55-11:25

Application of Energy-Dispersive X-ray Fluorescence Spectroscopy in the Screening and Management of Elemental Impurities

Zeng Li | Pre-sales Technical Support, Analytical & Measuring Instruments Division, Shimadzu

11:25-11:55

Technical Discussion on Compatibility Studies Between High-Risk Formulations and Pharmaceutical Packaging Materials

Pu Xiaocong | Deputy Director, Institute of Pharmaceutical Packaging Material Testing and Drug Compatibility Studies, Sichuan Provincial Institute for Drug Control (Sichuan Provincial Medical Device Testing Center)

Afternoon: Medical Device Special Session and Resource Matchmaking Meeting

14:00-14:30

Recommendations and Response Strategies for the Implementation of the New Version of the 9706 Series Standards

Guan Hui | Director of the Institute for Active Medical Device Testing, Sichuan Provincial Institute for Drug Control (Sichuan Provincial Medical Device Testing Center)

14:30-15:00

Exploration of Applications in Pharmaceutical and Medical Device Packaging

Shen Chen | Aolite Technical Engineer

15:00-15:30

Experience Sharing on MAH Registration Certificate Application

Hu Fei | Deputy General Manager and Co-Founder of Zhijian Medical

15:30-15:40

Tea Break

15:40-16:10

PMCF: Addressing Complex Issues

Wang Qian | General Manager, Chengdu Branch of Jiewen Consulting Group

16:10-16:40

Application of Biological Evaluation of Medical Devices Based on Biological Risk Analysis in High-Risk Medical Device Products

Xu Biao | Technical Lead, Biocompatibility Laboratory, WuXi AppTec China Medical Device Testing Center

16:40-17:00

Medical Device Special Session: Resource Promotion

In addition to the 20-minute resource promotion session in each conference, the event also features over 10 supplier booths to facilitate face-to-face communication between pharmaceutical and medical device R&D and manufacturing enterprises and on-site suppliers.

Chengdu Venue Layout

Meanwhile, the "China Biopharmaceutical Industry Resource Handbook" by Firestone Data Chain features over 100 high-quality service providers across the entire industry chain, facilitating more efficient connections to industrial resources. It covers drug R&D and manufacturing services, medical device R&D and manufacturing services, digitalization services, instruments, equipment, reagents and consumables, general services (talent, legal, patents, environmental protection, facility design, etc.), and industrial parks. On the day of the event, attendees who register for the offline salon can receive a complimentary copy of the Resource Handbook.

Huoshi Data Chain Service Resources, Efficiently Matching Demands

Huoshi Shulian has partnered with more than 300 major biopharmaceutical industrial parks across China, including the Beijing Yizhuang Biopharmaceutical Industrial Park, Zhongguancun Biopharmaceutical Industrial Park, Chengdu Tianfu Life Science and Technology Park, Tianfu International Bio-city, and Hangzhou Medicine Port. It provides biopharmaceutical enterprises within these parks with optimized allocation of full-industry-factor resources and services—covering talent, finance, policy, space, supply chain, professional technical services, regulatory affairs, and marketing and sales—to help them build more advanced R&D and supply chain systems and enhance internal and external collaborative efficiency.

On November 3, 2022, the Huoshi Shulian “Pharmaceutical and Medical Device Innovation Forum” Park Tour and CBIB Index Key Industrial Park Showcase [Hangzhou Stop] was successfully held in Hangzhou Medicine Port Town, attracting more than 200 pharmaceutical R&D and manufacturing enterprises from Hangzhou and surrounding cities.

In 2023, Huoshi Shulian’s offline “Park Tour” initiative underwent a comprehensive upgrade, with plans to visit over 300 partnered industrial parks across China. Focusing on six high-demand sectors—small-molecule drugs, peptides, nucleic acids, cell and gene therapy (CGT), antibodies, and innovative medical devices—the program aims to provide partners with more precise and in-depth networking and promotional services.

Scan the QR code to register for the Chengdu event now.

Business Cooperation: Mr./Ms. Zhou 18958106864 (WeChat ID same)

Media Collaboration: Mr./Ms. Yang 13682509815 (WeChat ID same)